 On Thursday, Sight Sciences Inc. NASDAQ:SGHT shares rallied more than 12 after reporting positive TearCare data. SGHT is exploring how TearCare could be used for localized heat therapy in adult patients with evaporative dry eye disease due to meibomian gland dysfunction. 